LAUREN OFFICER: Open Payments
NPI 1750811758 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 29 payments from 15 companies in 2025. Trend: 2023 $327 · 2024 $382 · 2025 $603
Food & beverage: $379Education: $223
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $151 |
| Daiichi Sankyo Inc. | 1 | $100 |
| Gilead Sciences, Inc. | 1 | $80 |
| Iovance Biotherapeutics, Inc. | 5 | $72 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Celgene Corporation | 2 | $27 |
| ABBVIE INC. | 1 | $16 |
| KYOWA KIRIN, INC. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: ENHERTU, Trodelvy, KISQALI, Amtagvi, SCEMBLIX, REBLOZYL, Fabhalta, PLUVICTO.
Industry payments across AR — which companies pay providers there.
